Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature

Hormone Research

Volumn 68, Issue 2, 2007, Pages 53-62

  Ranke, Michael B ^a,g   Lindberg, Anders ^b   Price, David A ^c   Darendeliler, Feyza ^d   Albertsson Wikland, Kerstin ^e   Wilton, Patrick ^b   Reiter, Edward O ^f  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b PFIZER INC   (United States)

^c ST MARY S HOSPITAL   (United Kingdom)

^d ISTANBUL UNIVERSITY   (Turkey)

^e QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^f TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Adult height; Growth hormone treatment; Height prediction; Idiopathic short stature

Indexed keywords

HUMAN GROWTH HORMONE;

ADOLESCENT; AGE; ARTICLE; BODY HEIGHT; BODY WEIGHT; CHILD; CORRELATION ANALYSIS; DATA BASE; FEMALE; HORMONAL THERAPY; HUMAN; IDIOPATHIC DISEASE; LONG TERM CARE; MALE; OUTCOME ASSESSMENT; PREPUBERTY; PRIORITY JOURNAL; SHORT STATURE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGE FACTORS; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GROWTH DISORDERS; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; MALE; MODELS, THEORETICAL; PUBERTY; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 34250180088     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098707     Document Type: Article

References (53)

1. Ranke MB: Towards a consensus on the definition of idiopathic short stature. Horm Res 1996;45:64-66.
2. Ranke MB, Grauer ML, Kistner K, Blum WF, Wollmann HA: Spontaneous adult height in idiopathic short stature. Horm Res 1995;44:152-157.
3. Rekers-Mombarg LTM, Wit JM, Massa GG, Ranke MB, Buckler JMH, Butenandt O, et al: Spontaneous growth in idiopathic short stature. Arch Dis Child 1996;75:175-180.
4. Barton JS, Gardineri HM, Cullen S, Hindmarsh PC, Brook CG, Preece MA: The growth and cardiovascular effects of high dose growth hormone therapy in idiopathic short stature. Clin Endocrinol (Oxf) 1995; 42:619-626.
5. Hopwood NJ, Hintz RL, Gertner JM, Attie KM, Johanson AJ, Baptista J, et al: Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy. J Pediatr 1993;123:215-222.
6. Lanes R: Effects of two years of growth hormone treatment in short, slowly growing non-growth hormone deficient children. J Pediatr Endocrinol Metab 1995;8:167-171.
7. Bernasconi S, Street ME, Volta C, Mazzardo G: Final height in non-growth hormone deficient children treated with growth hormone. The Italian Multicentre Study Group. Clin Endocrinol (Oxf) 1997;47:261-266.
8. Buchlis JG, Irizarry L, Crotzer BC, Shine BJ, Allen L, MacGillivray MH: Comparison of final heights of growth hormone-treated vs. untreated children with idiopathic growth failure. J Clin Endocrinol Metab 1998;83:1075-1079.
9. Coutant R, Rouleau S, Despert F, Magontier N, Loisel D, Limal JM: Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings. J Clin Endocrinol Metab 2001;86:4649-4654.
10. Hindmarsh PC, Brook CG: Final height of short normal children treated with growth hormone. Lancet 1996;348:13-16.
11. Hintz RL, Attie KM, Baptista J, Roche A: Effect of growth hormone treatment on adult height of children with idiopathic short stature. Genentech Collaborative Group. N Engl J Med 1999;340:502-507.
12. Kawai M, Momoi T, Yorifuji T, Yamanaka C, Sasaki H, Furusho K: Unfavorable effects of growth hormone therapy on the final height of boys with short stature not caused by growth hormone deficiency. J Pediatr 1997; 130:205-209.
13. Loche S, Cambiaso P, Setzu S, Carta D, Marini R, Borrelli P, et al: Final height after growth hormone therapy in non-growth-hormone-deficient children with short stature. J Pediatr 1994;125:196-200.
14. Lopez-Siguero JP, Garcia-Garcia E, Carralero I, Martinez-Aedo MJ: Adult height in children with idiopathic short stature treated with growth hormone. J Pediatr Endocrinol Metab 2000;13:1595-1602.
15. Wit JM, Kamp GA, Rikken B: Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature. Pediatr Res 1996;39:295-302.
16. Zadik Z, Zung A: Final height after growth hormone therapy in short children: correlation with siblings' height. Horm Res 1997;48:274-277.
17. Leschek EW, Rose SR, Yanovski JA, Troendle JF, Quigley CA, Chipman JJ, et al: Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2004;89:3140-3148.
18. Maneatis T, Baptista J, Connelly K, Blethen S: Growth hormone safety update from the National Cooperative Growth Study. J Pediatr Endocrinol Metab 2000;13(suppl 2):1035-1044.
19. Wit J-M: Growth Hormone Treatment of Idiopathic Short Stature in KIGS;in Ranke MB, Wilton P (eds): Growth Hormone Therapy in KIGS: 10 Years' Experience. Heidelberg-Leipzig, Johann Ambrosius Barth Verlag, 1999, pp 225-243.
20. Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson W, et al: Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study. J Clin Endocrinol Metab 1999;84:1174-1183.
21. Tanner JM, Whitehouse RH, Takaishi M: Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. Part II. Arch Dis Child 1966;41:613-635.
22. Freeman JV, Cole TJ, Chinn S, Jones PR, White EM, Preece MA: Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 1995;73:17-24.
23. Niklasson A, Ericson A, Fryer JG, Karlberg J, Lawrence C, Karlberg P: An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age (1977-1981). Acta Paediatr Scand 1991;80:756-762.
24. de Muinck Keizer-Schrama SM, Sas TC: Growth hormone treatment regimens in girls with Turner syndrome. Dutch Advisory Group on Growth Hormone. Acta Paediatr 1999;88(suppl):126-129.
25. Greulich W, Pyle S: Radiographic Atlas of the Skeletal Development of the Hand and Wrist. Stanford, Stanford University Press, 1959.
26. Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, et al: Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. J Clin Endocrinol Metab 2000;85:4212-4218.
27. Ranke MB, Lindberg A, Cowell CT, Albertsson-Wikland K, Reiter EO, Wilton P, et al: Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database). J Clin Endocrinol Metab 2003;88:125-131.
28. Cook RD, Weisberg S: Residuals and Influence in Regression. New York, Chapman & Hall, 1982.
29. Weisberg S: Applied Linear Regression. Chichester, Wiley, 1985.
30. Bayley N, Pinneau SR: Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr 1952;40:423-441.
31. Bramswig JH, Fasse M, Holthoff ML, von Lengerke HJ, von Petrykowski W, Schellong G: Adult height in boys and girls with untreated short stature and constitutional delay of growth and puberty: accuracy of five different methods of height prediction. J Pediatr 1990;117:886-891.
32. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, et al: Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002;109:45-60.
33. Price DA: Spontaneous adult height in patients with idiopathic short stature. Horm Res 1996;45:59-63.
34. Rao E, Weiss B, Fukami M, Rump A, Niesler B, Mertz A, et al: Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 1997;16:54-63.
35. Allen DB, Fost N: hGH for short stature: ethical issues raised by expanded access. J Pediatr 2004;144:648-652.
36. Downie AB, Mulligan J, Stratford RJ, Betts PR, Voss LD: Are short normal children at a disadvantage? The Wessex growth study. BMJ 1997;314:97-100.
37. Stabler B, Siegel PT, Clopper RR, Stoppani CE, Compton PG, Underwood LE: Behavior change after growth hormone treatment of children with short stature. J Pediatr 1998;133:366-373.
38. Voss LD: Short normal stature and psychosocial disadvantage: a critical review of the evidence. J Pediatr Endocrinol Metab 2001;14:701-711.
39. Haverkamp F, Ranke MB: The ethical dilemma of growth hormone treatment of short stature: a scientific theoretical approach. Horm Res 1999;51:301-304.
40. Kelnar CJ, Albertsson-Wikland K, Hintz RL, Ranke MB, Rosenfeld RG: Should we treat children with idiopathic short stature? Horm Res 1999;52:150-157.
41. Underwood LE: Report of the conference on uses and possible abuses of biosynthetic human growth hormone. N Engl J Med 1984;311:606-608.
42. Wilton P: Adverse events during GH treatment: 10 years' experience in KIGS, a pharmacoepidemiological survey;in Ranke MB, Wilton P (eds): Growth Hormone Therapy in KIGS: 10 Years' Experience. Heidelberg-Leipzig, Johann Ambrosius Barth Verlag, 1999, pp 349-364.
43. Cuttler L, Silvers JB, Singh J, Marrero U, Finkelstein B, Tannin G, et al: Short stature and growth hormone therapy: a national study of physician recommendation patterns. JAMA 1996;276:531-537.
44. Root AW, Kemp SF, Rundle AC, Dana K, Attie KM: Effect of long-term recombinant growth hormone therapy in children: the National Cooperative Growth Study, USA, 1985-1994. J Pediatr Endocrinol Metab 1998;11:403-412.
45. Ranke MB, Lindberg A, Martin DD, Bakker B, Wilton P, Albertsson W, et al: The mathematical model for total pubertal growth in idiopathic growth hormone (GH) deficiency suggests a moderate role of GH dose. J Clin Endocrinol Metab 2003;88:4748-4753.
46. Wit JM, Boersma B, de Muinck Keizer-Schrama SM, Nienhuis HE, Oostdijk W, Otten BJ, et al: Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group. Clin Endocrinol (Oxf) 1995;42:365-372.
47. McCaughey ES, Mulligan J, Voss LD, Betts PR: Randomised trial of growth hormone in short normal girls. Lancet 1998;351:940-944.
48. Wit JM, Rekers-Mombarg LT: Final height gain by GH therapy in children with idiopathic short stature is dose dependent. J Clin Endocrinol Metab 2002;87:604-611.
49. Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, et al: Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. J Pediatr 2005;146:45-53.
50. Finkelstein BS, Imperiale TF, Speroff T, Marrero U, Radcliffe DJ, Cuttler L: Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis. Arch Pediatr Adolesc Med 2002;156:230-240.
51. Kamp GA, Waelkens JJ, de Muinck Keizer-Schrama SM, Delemarre-van de Waal HA, Verhoeven-Wind L, Zwinderman AH, et al: High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature. Arch Dis Child 2002;87:215-220.
52. Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J: High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group. J Clin Endocrinol Metab 2000;85:3653-3660.
53. Ranke MB, Guilbaud O, Lindberg A, Cole T: Prediction of the growth response in children with various growth disorders treated with growth hormone: analyses of data from the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study. Acta Paediatr 1993;82(suppl 391):82-88.